GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - February 23, 1999JAMC - le 23 février 1999

The cost of obesity in Canada

Table 2: Estimated direct costs of obesity and the selected comorbidities*
Comorbidity Expenditure category; cost, $ thousands  
Hospital care† Physician services Services of other health professionals Drugs‡ Other health care Health research Total cost, $ thousands Cost attributable to obesity, $ thousands§
Breast cancer, postmenopausal 92 821 31 926 3 963 44 350 37 513 6 817 217 390 19 782
Coronary artery disease 1 080 329 275 225 34 160 318 160 222 116 2 727 1 932 717 345 956
Colorectal cancer 239 787 57 247 7 105 38 565 66 141 15 724 424 569 19 955
Endometrial cancer 23 205 6 605 820 8 677 7 897 1 363 48 567 12 919
Gallbladder disease 262 992 128 805 15 987 147 510 105 628 5 544 666 466 137 292
Hyperlipidemia 126 339 NA NA 372 308 48 372 NA 547 019 61 266
Hypertension 97 977 265 317 75 655 1 071 137 567 629 NA 2 077 715 656 558
Pulmonary embolism 92 821 NA NA NA 35 538 NA 128 359 38 251
Stroke 2 036 897 77 063 9 565 318 160 394 872 909 2 837 466 106 943
Type 2 diabetes 304 245 128 805 36 729 190 896 155 974 17 996 834 645 423 165
Total 9 714 913 1 822 087
Note: NA = not available.
*Amounts are given in 1997 Canadian dollars.
†Includes cost of hospital drugs.
‡Excludes cost of hospital drugs.
§This cost was derived by multiplying the total cost for a given comorbidity by its respective PAF (Table 1).

[Return to text]